Castlight Health (CSLT) completed the fourth technology IPO of the year, and its 149% first day return brought the sector's average up to 95% for 2014. Castlight was also the ...read more
Last week's two biotech IPOs - Aquinox Pharmaceuticals (AQXP) and Recro Pharma (REPH) - posted an average return of only 6% on their first day of trading on Friday. While Recro has continued to trade poorly, Aquinox has enjoyed a strong week, bringing its...read more
Dipexium Pharmaceuticals, a late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections, raised $33 million by offering 2.8 million shares (upsized from 2.3 million) at $12, the low end of the $12 to $14 range. Dipexium Pharmaceuticals...read more
US IPO Recap: Castlight Health's 149% pop shows healthy tech demand
Castlight Health (CSLT) completed the fourth technology IPO of the year, and its 149% first day return brought the sector's average up to 95% for 2014. Castlight was also the ...read more
Biotechs post better returns this week before an IPO tech wave
Last week's two biotech IPOs - Aquinox Pharmaceuticals (AQXP) and Recro Pharma (REPH) - posted an average return of only 6% on their first day of trading on Friday. While Recro has continued to trade poorly, Aquinox has enjoyed a strong week, bringing its...read more
Dipexium prices upsized IPO at $12, the low end of the range
Dipexium Pharmaceuticals, a late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections, raised $33 million by offering 2.8 million shares (upsized from 2.3 million) at $12, the low end of the $12 to $14 range. Dipexium Pharmaceuticals...read more
6 US IPOs planned for the week of Mar 10
The following IPOs are expected to price this week: Achaogen (AKAO), which is developing antibiotic treatments of multi-drug resistant infections, plans to raise $65...read more